Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
funding round
MedTech
HistoSonics reels in $250M in funding months after sale
Cancer treatment developer HistoSonics reeled in $250 million in a series D round of financing two months after it sold to a group for $2.5 billion.
Joseph Keenan
Oct 20, 2025 9:10am
Neuralink secures $650M to develop new devices
Jun 4, 2025 11:26am
Bain unveils $3B fund for life science companies
Sep 10, 2024 11:20am
Labcorp, Quest Diagnostics back PreciseDx's $20.7M series B
Aug 21, 2024 11:00am
Tempus AI IPO drives $6.6B in VC exit value for medtech sector
Aug 21, 2024 10:21am
PhaseV reaps $15M in funding to streamline trial design
Oct 24, 2023 10:55am
